AAMS Neurology & Neurosciences · Vol. 7 · Issue 3 · 2026-03-01
Stem Cell Therapy for Amyotrophic Lateral Sclerosis: Phase II Efficacy Results
Andersson P, Kato N, Abdi-Rashid H
Sahlgrenska Academy, Gothenburg, Sweden; University of Tokyo, Tokyo, Japan; Mogadishu University, Mogadishu, Somalia
Abstract
Phase II randomized controlled trial evaluating intrathecal mesenchymal stem cell transplantation in 120 patients with ALS, assessing functional decline rates and survival.
Keywords: ALS, stem cell therapy, mesenchymal stem cells, phase II, motor neuron disease
Full Text
Phase II randomized controlled trial evaluating intrathecal mesenchymal stem cell transplantation in 120 patients with ALS, assessing functional decline rates and survival.
This article is published open access by AAMS Neurology & Neurosciences. The complete peer-reviewed text can be read on the journal page.
Author Citation Metrics
Metrics are sourced from public bibliometric records (OpenAlex) and each author's Google Scholar profile.